![](/img/cover-not-exists.png)
1023PUse of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients
Berton-Rigaud, D, Floquet, A, Mollon-Grange, D, Dechartres, A, Lescaut, W, Kaminsky-Forrett, M-C, Tredan, O, Largillier, R, Savoye, A M, Alexandre, J, Delbaldo, C, Malaurie, E, Barletta, H, Bosacki, CVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.031
Date:
October, 2019
File:
PDF, 78 KB
2019